Cargando…

The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson’s Disease

BACKGROUND: Alpha-synuclein is a constituent of Lewy bodies and mutations of its gene cause familial Parkinson’s disease (PD). A previous study showed that a variant of the alpha-synuclein gene (SNCA), namely the 263 bp allele of Rep1 was associated with faster motor progression in PD. On the contra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corrado, Lucia, De Marchi, Fabiola, Tunesi, Sara, Oggioni, Gaia Donata, Carecchio, Miryam, Magistrelli, Luca, Tesei, Silvana, Riboldazzi, Giulio, Di Fonzo, Alessio, Locci, Clarissa, Trezzi, Ilaria, Zangaglia, Roberta, Cereda, Cristina, D’Alfonso, Sandra, Magnani, Corrado, Comi, Giacomo P., Bono, Giorgio, Pacchetti, Claudio, Cantello, Roberto, Goldwurm, Stefano, Comi, Cristoforo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890103/ https://www.ncbi.nlm.nih.gov/pubmed/29662465 http://dx.doi.org/10.3389/fneur.2018.00213

Ejemplares similares

Predicting Cognitive Decline in Parkinson’s Disease: Can We Ask the Genes?
por: De Marchi, Fabiola, et al.
Publicado: (2014)

The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson’s Disease
por: Magistrelli, Luca, et al.
Publicado: (2021)

Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series
por: Magistrelli, Luca, et al.
Publicado: (2021)

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient
por: Contaldi, Elena, et al.
Publicado: (2021)

Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians
por: De Marchi, Fabiola, et al.
Publicado: (2021)

Revisiting the Molecular Mechanism of Neurological Manifestations in Antiphospholipid Syndrome: Beyond Vascular Damage
por: Carecchio, M., et al.
Publicado: (2014)

The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson’s Disease and SNCA Gene Methylation
por: Iakovenko, E. V., et al.
Publicado: (2020)

Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence
por: Magistrelli, Luca, et al.
Publicado: (2019)

Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know?
por: Magistrelli, Luca, et al.
Publicado: (2022)

Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review
por: Lombardi, Michele, et al.
Publicado: (2023)

Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy
por: Fleetwood, Thomas, et al.
Publicado: (2018)

T Lymphocytes in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2022)

SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population
por: Trotta, Luca, et al.
Publicado: (2012)

Treatment of Chronic Inflammatory Demyelinating Polyneuropathy: From Molecular Bases to Practical Considerations
por: Ripellino, Paolo, et al.
Publicado: (2014)

Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
por: Contaldi, Elena, et al.
Publicado: (2022)

The Role of Tau beyond Alzheimer’s Disease: A Narrative Review
por: Virgilio, Eleonora, et al.
Publicado: (2022)

Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
por: Kustrimovic, Natasa, et al.
Publicado: (2018)

SNCA Rep1 microsatellite length influences non-motor symptoms in early Parkinson’s disease
por: Yong, Alisa CW, et al.
Publicado: (2020)

Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson’s Disease: A Single-Center Longitudinal Study
por: Contaldi, Elena, et al.
Publicado: (2022)

SNCA-AS1 in aging and Parkinson’s disease
por: Carelli, Stephana, et al.
Publicado: (2022)

Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers
por: Tondo, Giacomo, et al.
Publicado: (2022)

Susac Syndrome: an uncommon cause of impaired vision
por: Barbero, Paolo, et al.
Publicado: (2022)

The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey
por: Martini, Stefano, et al.
Publicado: (2022)

The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease
por: Martini, Stefano, et al.
Publicado: (2023)

α‐Synuclein antisense transcript SNCA‐AS1 regulates synapses‐ and aging‐related genes suggesting its implication in Parkinson's disease
por: Rey, Federica, et al.
Publicado: (2021)

Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis
por: Virgilio, Eleonora, et al.
Publicado: (2023)

Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study
por: Contaldi, Elena, et al.
Publicado: (2021)

Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2021)

Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain
por: Cronin, Kenneth D., et al.
Publicado: (2009)

Prognostic Role of Visual Evoked Potentials in Non-Neuritic Eyes at Multiple Sclerosis Diagnosis
por: Vecchio, Domizia, et al.
Publicado: (2023)

Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
por: De Marchi, Fabiola, et al.
Publicado: (2023)

Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
por: Magistrelli, Luca, et al.
Publicado: (2021)

Serum Vitamin D as a Marker of Impaired Information Processing Speed and Early Disability in Multiple Sclerosis Patients
por: Virgilio, Eleonora, et al.
Publicado: (2021)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

DJ1 analysis in a large cohort of Italian early onset Parkinson Disease patients()
por: Sironi, Francesca, et al.
Publicado: (2013)

K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up
por: Crespi, Ilaria, et al.
Publicado: (2019)

The Yin-Yang of osteopontin in nervous system diseases: damage versus repair
por: Cappellano, Giuseppe, et al.
Publicado: (2020)

Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study
por: Cilia, Roberto, et al.
Publicado: (2023)

Design and Operation of the Lombardy Parkinson's Disease Network
por: Albanese, Alberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0vcbcbnq069p5d6ue5lvm2jrv7